Ibukron

Ibuprofen, the active ingredient in Ibukron, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is employed to relieve mild to moderate pain, reduce fever, and manage inflammatory conditions such as arthritis in adults and children when appropriate.

GNH USA supplies Ibukron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable logistics for global distribution and timely delivery to meet patient needs.

Ibukron (ibuprofen) works by inhibiting cyclooxygenase enzymes, thereby providing analgesic, antipyretic, and anti‑inflammatory benefits across several common conditions in adult and pediatric patients. - Mild to moderate pain: reduces perception of pain associated with headaches, dental procedures, musculoskeletal strain, postoperative discomfort, and menstrual cramps. - Fever: lowers elevated body temperature by acting on the hypothalamic heat‑regulation center, helping improve comfort during febrile illnesses. - Arthritis and other inflammatory conditions: diminishes joint swelling, stiffness, and pain in osteoarthritis and rheumatoid arthritis, improving functional mobility.

Ibukron may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate tension‑type headache. - Dizziness or vertigo: transient sensation of light‑headedness. - Skin rash: mild erythema or pruritus. - Edema: mild peripheral swelling. - Insomnia: difficulty falling asleep.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: severe abdominal pain, melena, or hematemesis. - Renal impairment: sudden decrease in urine output or elevated creatinine. - Hypersensitivity reactions: anaphylaxis, angioedema, or severe skin reactions such as Stevens‑Johnson syndrome. - Cardiovascular events: increased risk of myocardial infarction or stroke.

When using Ibukron, certain precautions should be observed to minimize risks and ensure safe therapy. - Assess renal function: evaluate kidney health before initiating therapy, especially in patients with pre‑existing renal disease. - Monitor gastrointestinal risk: use lowest effective dose and consider gastro‑protective agents in individuals with ulcer history. - Evaluate cardiovascular status: avoid prolonged high‑dose use in patients with heart disease or uncontrolled hypertension. - Check for hypersensitivity: discontinue immediately if signs of allergic reaction appear. - Use caution in pregnancy and lactation: consult healthcare professional before use in pregnant or breastfeeding women. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Ibukron can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk; monitor coagulation parameters closely. - Other NSAIDs or aspirin: additive gastrointestinal toxicity; avoid concurrent use. - Selective serotonin reuptake inhibitors (SSRIs): heightened risk of upper GI bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function; monitor serum creatinine and potassium. - Diuretics: potential for reduced diuretic effect and renal impairment; assess fluid balance. - Lithium: ibuprofen may increase lithium levels; check serum concentrations regularly.